학술논문

Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial
Document Type
Article
Source
In: European Journal of Cancer. (European Journal of Cancer, March 2024, 199)
Subject
Language
English
ISSN
18790852
09598049